Tag Archives: Sunshine Act

The Sunshine Act Makes for Gloomy Sales Reps

On Café Pharma message boards, the drug industry’s online water cooler, anonymous sales reps are sounding off on the Physician Payment Sunshine Act and its implications for their battered profession. Here’s a selection from a thread that PharmExec came across, edited for spelling, punctuation, and coherence:
Posted in Advertising, compliance, Marketing, Medical Education, Regulatory, Sales, social media | Also tagged , , | 2 Comments

CMS taps IT firm CGI for Sunshine Act Data Dump

Speaking at CBI’s Sunshine & Aggregate Spend Conference in Washington DC on Tuesday, Shantanu Agrawal, director, data sharing and partnership group, center for program integrity, CMS, said the agency hired IT company CGI to build the software platform to be used for publishing pharma payments to physicians under the Sunshine Act provisions, now re-branded “open […]
Posted in Agency Insight, Deals, E-Media, FDA, healthcare, People, Technology | Also tagged , , , , , , , , , , , , , , | Leave a comment

Compliance and Reporting: The Case for a Single System

by James Pierce Pharmaceutical companies are awash in a sea of compliance regulations that affect their business operations both inside and outside the US. This August, one more compliance wave will crest when the Physician Payments Sunshine Act (PPSA) begins requiring pharmaceutical companies to track and report virtually all payments to health care providers (HCPs). […]
Posted in compliance, Corporate Responsibility, E-Media, Europe, FDA, Global, Guest Blog, Marketing, Regulatory, social media, Strategy, Technology | Also tagged , , , , , , | Leave a comment

"Sunshine" Just the Tip of the Iceberg: Pharma and Full Disclosure

“Sunshine” Just the Tip of the Iceberg: Full Disclosure for Pharma:??There seems no end to demands for data on clinical research, conflicts of interest, company payments, and drug prices, writes Jill Wechsler. Although recent legislation and regulations have greatly expanded the range of information that pharmaceutical companies have to unveil to the public, there’s an […]
Posted in Guest Blog, healthcare, Op-Ed, pricing, Regulatory, Safety, Strategy | Also tagged , , , | 1 Comment

The Sunshine Act: Cloudier Still?

With the recent release of the Patient Protection Sunshine Act (PPSA), the Center for Medicare and Medicaid Services (CMS) has established reporting requirements to ensure that drug manufacturers properly disclose payments to physicians in areas of research, continuing medical education, etc. However a key uncertainty is the issue of state pre-emption. While state and local […]
Posted in compliance, Legal, Manufacturing, Medical Education, Meetings, Regulatory | Also tagged , | 1 Comment
  • Categories

  • Meta